Under Health and Human Services Secretary Robert Kennedy’s leadership, the Food and Drug Administration has announced that a proposed rule is on the way to crack down on pharmaceutical advertising in the United States. While concerns about the influence of Big Pharma are understandable, conservatives should be wary of the precedent such actions would set.
